12:00 AM
 | 
Jun 12, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Genstar Therapeutics preclinical data

GNT said that in rodents, its Factor VIII gene therapy delivered using a mini-adenoviral vector system was...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >